EssilorLuxottica, FR0000121667

EssilorLuxottica stock fell 1.24 percent as targets diverged

Published on 10/04/2026 at 18:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EssilorLuxottica stock stood at EUR 142.80 on October 2, 2026, after a 1.24 percent decline. First-half revenue rose 9.7 percent at constant exchange rates.

Paris-Aquarell: Haussmann-Fassaden und Seine in Pastellfarben
EssilorLuxottica FR0000121667 Paris-Aquarell zeigt Stadtansicht der Seine Haussmann-Architektur in impressionistischer locker gemalter Malereitechnik, Illustration mit AI erstellt.

EssilorLuxottica stock (ISIN FR0000121667) fell 1.24 percent to EUR 142.80 on Euronext Paris on October 2, 2026, with 636,229 shares changing hands. The move came as the eyewear group expanded its hearing-glasses business while analyst targets continued to diverge.

New hearing glasses broaden the story

EssilorLuxottica launched Nuance Audio Plus on September 29, according to Simply Wall St. The FDA-cleared open-ear product starts at USD 829 in the United States and adds improved audio performance, longer battery life and hands-free calling.

The launch extends the company beyond traditional lenses, frames and sunglasses into medical and connected eyewear. That strategy offers a second growth path alongside Ray-Ban Meta, but it also puts greater weight on product adoption, distribution and execution.

H1 growth outpaced revenue

EssilorLuxottica reported first-half 2026 revenue growth of 9.7 percent at constant exchange rates and 5.7 percent at current exchange rates, according to the Yahoo Finance transcript of the July 28 results call. Adjusted operating profit advanced 15 percent, faster than reported revenue, while first-half free cash flow reached EUR 1.067 billion.

The second quarter delivered 8.7 percent constant-currency revenue growth and 7.2 percent growth at current exchange rates. Management also cited an 80-basis-point improvement in the operating-expense ratio at constant exchange rates, giving investors a measurable profitability counterweight to the share-price decline.

Targets remain far above the stock

A consensus of 23 analysts carries a Buy rating and an average target of EUR 232.61, with a low of EUR 135.00 and a high of EUR 361.00, according to Stock Analysis. The average target lies 62.9 percent above the October 2 price.

Barclays cut its target from EUR 265.00 to EUR 260.00 on September 30 while keeping an Overweight rating, as reported by Markets Insider. The firm expects growth to moderate in the second half because of difficult wearables comparisons.

Stock sits near its yearly floor

At EUR 142.80, the shares were EUR 4.50 above the 52-week low of EUR 138.30 and EUR 181.00 below the 52-week high of EUR 323.80 on October 2. EssilorLuxottica carried a market capitalization of EUR 65.6 billion and traded between EUR 142.75 and EUR 146.70 during that session.

For investors, the central test is whether faster profit growth and new connected products can narrow the gap between operating performance and valuation expectations. The next company checkpoint is the Q3 revenue release scheduled for October 20, 2026, according to Zonebourse.

EssilorLuxottica stock holds a key level

EssilorLuxottica stock was last at EUR 142.80 on Euronext Paris on October 2, 2026 at 5:35 p.m. CEST, down 1.24 percent for the session. The price remained above the EUR 138.30 52-week low.

EssilorLuxottica stock at a glance

  • Company: EssilorLuxottica S.A.
  • ISIN: FR0000121667
  • Ticker: EL
  • Trading venue: Euronext Paris
  • Price (as of October 2, 2026, 5:35 p.m. CEST): EUR 142.80
  • Market capitalization: EUR 65.6 billion (as of October 2, 2026)
  • 52-week range: EUR 138.30-323.80 (as of October 2, 2026)
  • Sector / Industry: Healthcare / Medical instruments and supplies
  • Index membership: CAC 40

Upcoming dates for EssilorLuxottica stock

  • October 20, 2026: Q3 2026 revenue release

More news and analyses on EssilorLuxottica stock

Disclaimer...

en | FR0000121667 | ESSILORLUXOTTICA | boerse | 70227271 | bgmi